Literature DB >> 28729520

Challenges and emerging opportunities for the HIV prevention, treatment and care cascade in men who have sex with men in Asia Pacific.

Frits van Griensven1, Thomas E Guadamuz2, Jan Willem de Lind van Wijngaarden3, Nittaya Phanuphak4, Sunil Suhas Solomon5, Ying-Ru Lo6.   

Abstract

In Asia Pacific, most countries have expanded HIV treatment guidelines to include all those with HIV infection and adopted antiretroviral treatment for prevention (TFP) as a blanket strategy for HIV control. Although the overall epidemic development associated with this focus is positive, the HIV epidemic in men who have sex with men (MSM) is continuing unperturbed without any signs of decline or reversal. This raises doubt about whether TFP as a blanket HIV prevention policy is the right approach. This paper reviews currently available biomedical HIV prevention strategies, national HIV prevention policies and guidelines from selected countries and published data on the HIV cascade in MSM. No evidence for efficacy of TFP in protecting MSM from HIV infection was found. The rationale for this approach is based on assumptions about biological plausibility and external validity of latency-based efficacy found in heterosexual couples. This is different from the route and timing of HIV transmission in MSM. New HIV infections in MSM principally occur in chains of acutely HIV-infected highly sexually active young men, in whom acquisition and transmission are correlated in space and time. By the time TFP renders its effects, most new HIV infections in MSM will have already occurred. On a global level, less than 6% of all reports regarding the HIV care cascade from 1990 to 2016 included MSM, and only 2.3% concerned MSM in low/middle-income countries. Only one report originated from Asia Pacific. Generally, HIV cascade data in MSM show a sobering picture of TFP in engaging and retaining MSM along the continuum. Widening the cascade with a preventive extension, including pre-exposure prophylaxis, the first proven efficacious and only biomedical HIV prevention strategy in MSM, will be instrumental in achieving HIV epidemic control in this group. © Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2017. All rights reserved. No commercial use is permitted unless otherwise expressly granted.

Entities:  

Keywords:  HIV; acquired Immunodeficiency syndrome; antiretroviral therapy; pre-exposure prophylaxis; prevention and control; sexual behavior

Mesh:

Year:  2017        PMID: 28729520     DOI: 10.1136/sextrans-2016-052669

Source DB:  PubMed          Journal:  Sex Transm Infect        ISSN: 1368-4973            Impact factor:   3.519


  8 in total

1.  Geospatial modelling in guiding health program strategies in resource-limited settings-the way forward.

Authors:  Diane Gu; Chawangwa Modongo; Sanghyuk S Shin; Nicola M Zetola
Journal:  Ann Transl Med       Date:  2017-12

2.  A Mobile Phone App to Support Adherence to Daily HIV Pre-exposure Prophylaxis Engagement Among Young Men Who Have Sex With Men and Transgender Women Aged 15 to 19 Years in Thailand: Pilot Randomized Controlled Trial.

Authors:  Surinda Kawichai; Wipaporn Natalie Songtaweesin; Prissana Wongharn; Nittaya Phanuphak; Tim R Cressey; Juthamanee Moonwong; Anuchit Vasinonta; Chutima Saisaengjan; Tanat Chinbunchorn; Thanyawee Puthanakit
Journal:  JMIR Mhealth Uhealth       Date:  2022-04-21       Impact factor: 4.947

Review 3.  Defining rights-based indicators for HIV epidemic transition.

Authors:  Joseph J Amon; Patrick Eba; Laurel Sprague; Olive Edwards; Chris Beyrer
Journal:  PLoS Med       Date:  2018-12-21       Impact factor: 11.069

4.  What Works? Prevention and Control of Sexually Transmitted Infections and Blood-Borne Viruses in Migrants from Sub-Saharan Africa, Northeast Asia and Southeast Asia Living in High-Income Countries: A Systematic Review.

Authors:  Sajana Ghimire; Jonathan Hallett; Corie Gray; Roanna Lobo; Gemma Crawford
Journal:  Int J Environ Res Public Health       Date:  2019-04-10       Impact factor: 3.390

5.  Go Where the Virus Is: An HIV Micro-epidemic Control Approach to Stop HIV Transmission.

Authors:  Michael M Cassell; Rose Wilcher; Reshmie A Ramautarsing; Nittaya Phanuphak; Timothy D Mastro
Journal:  Glob Health Sci Pract       Date:  2020-12-23

6.  Pre-exposure prophylaxis (PrEP) for MSM in low HIV incidence places: should high risk individuals be targeted?

Authors:  Ngai Sze Wong; Tsz Ho Kwan; Owen T Y Tsang; Man Po Lee; Wing Cheong Yam; Wilson Lam; Wai Shing Leung; Jacky M C Chan; Kai Man Ho; Shui Shan Lee
Journal:  Sci Rep       Date:  2018-08-03       Impact factor: 4.379

7.  Youth-friendly services and a mobile phone application to promote adherence to pre-exposure prophylaxis among adolescent men who have sex with men and transgender women at-risk for HIV in Thailand: a randomized control trial.

Authors:  Wipaporn Natalie Songtaweesin; Surinda Kawichai; Nittaya Phanuphak; Tim R Cressey; Prissana Wongharn; Chutima Saisaengjan; Tanat Chinbunchorn; Surang Janyam; Danai Linjongrat; Thanyawee Puthanakit
Journal:  J Int AIDS Soc       Date:  2020-09       Impact factor: 5.396

8.  Molecular epidemiology of a primarily MSM acute HIV-1 cohort in Bangkok, Thailand and connections within networks of transmission in Asia.

Authors:  David Chang; Eric Sanders-Buell; Meera Bose; Anne Marie O'Sullivan; Phuc Pham; Eugene Kroon; Donn J Colby; Rujipas Sirijatuphat; Erik Billings; Suteeraporn Pinyakorn; Nitiya Chomchey; Wiriya Rutvisuttinunt; Gustavo Kijak; Mark de Souza; Jean-Louis Excler; Praphan Phanuphak; Nittaya Phanuphak; Robert J O'Connell; Jerome H Kim; Merlin L Robb; Nelson L Michael; Jintanat Ananworanich; Sodsai Tovanabutra
Journal:  J Int AIDS Soc       Date:  2018-11       Impact factor: 5.396

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.